소아의 중이염 및 폐렴 예방을 위한 백신

키워드

참고문헌 (51)

1. Winther B, "Viral respiratory infection in schoolchildren: effects on middle ear pressure", Pediatrics, 826, pp.832~ (2002)
2. Sanyal MA, "Effect of upper respiratory tract infection on eustachian tube ventilatory function in the preschool child", J Pediatr, 97, pp.11~15 (1980)
3. Ruuskanen O, "Otitis media: etiology and diagnosis", Pediatr Infect Dis J, 13, pp.223~226 (1994)
4. Heikkinen T, "Prevalence of various respiratory viruses in the middle ear during acute otitis media", N Engl J Med, 340, pp.260~264 (1999)
5. Chonmaitree T, "Viral upper respiratory tract infection and otitis media complication in young children", Clin Infect Dis, 46, pp.815~823 (2008)
6. De Wals P, "How to compare the efficacy of conjugate vaccines to prevent acute otitis media?", Vaccine, 27, pp.2877~2883 (2009)
7. Black S, "Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children", Pediatr Infect Dis J, 19, pp.187~195 (2000)
8. Fireman B, "Impact of the pneumococcal conjugate vaccine on otitis media", Pediatr Infect Dis J, 22, pp.10~16 (2003)
9. Eskola J, "Efficacy of a pneumococcal conjugate vaccine against acute otitis media", N Engl J Med, 344, pp.403~409 (2001)
10. Palmu A, "The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children", Pediatr Infect Dis J, 23, pp.732~738 (2004)
11. Dagan R, "Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees", Pediatr Infect Dis J, 20, pp.951~958 (2001)
12. O'Brien KL, "Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants", Pediatr Infect Dis J, 27, pp.71~73 (2008)
13. Kilpi T, "Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharidemeningococcal outer membrane protein complex conjugate vaccine in 1666 children", Clin Infect Dis, 37, pp.1155~1164 (2003)
14. Prymula R, "Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study", Lancet, 367, pp.740~748 (2006)
15. Veenhoven R, "Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomized study", Lancet, 361, pp.2189~2195 (2003)
16. Block SL, "Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media", Pediatr Infect Dis J, 23, pp.829~833 (2004)
17. Grijalva CG, "National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States", Pediatrics, 118, pp.865~873 (2006)
18. Poehling KA, "Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine", Pediatrics, 119, pp.707~715 (2007)
19. Heikkinen T, "Burden of influenza in children in the community", J Infect Dis, 190, pp.1369~1373 (2004)
20. Clements DA, "Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care", Arch Pediatr Adolesc Med, 149, pp.1113~1117 (1995)
21. Heikkinen T, "Influenza vaccination in the prevention of acute otitis media in children", Am J Dis Child, 145, pp.445~448 (1991)
22. Hoberman A, "Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial", JAMA, 290, pp.1608~1616 (2003)
23. Ozgur SK, "Effectiveness of inactivated influenza vaccine for prevention of otitis media in children", Pediatr Infect Dis J, 25, pp.401~404 (2006)
24. Belshe RB, "The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children", N Engl J Med, 338, pp.1405~1412 (1998)
25. Manzoli L, "The efficacy of influenza vaccine for healthy children: a metaanalysis evaluating potential sources of variation in efficacy estimates including study quality", Pediatr Infect Dis J, 266, pp.97~106 (2007)
26. McIntosh K, "Community-acquired pneumonia in children", N Engl J Med, 346, pp.429~437 (2002)
27. Shann F, "Haemophilus influenzae pneumonia: type b or non-type b?", Lancet, 354, pp.1488~1490 (1999)
28. Madhi SA, "Vaccines to prevent pneumonia and improve child survival", Bull World Health Organ, 86, pp.365~372 (2008)
29. Mulholland K, "Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine", Lancet, 349, pp.1191~1197 (1997)
30. Levine OS, "Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b", Pediatr Infect Dis J, 18, pp.1060~1064 (1999)
31. Gessner BD, "Incidences of vaccinepreventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial", Lancet, 365, pp.43~52 (2005)
32. de Andrade AL, "Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil", Int J Epidemiol, 33, pp.173~181 (2004)
33. de la Hoz F, "Effectiveness of Haemophilus influenzae type b vaccination against bacterial pneumonia in Colombia", Vaccine, 23, pp.36~42 (2004)
34. Baqui AH, "Effectiveness of Haemophilus influenzae type b conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study", Pediatr Infect Dis J, 26, pp.565~571 (2007)
35. Hansen J, "Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs", Pediatr Infect Dis J, 25, pp.779~781 (2006)
36. Klugman KP, "A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection", N Engl J Med, 349, pp.1341~1348 (2003)
37. Cutts FT, "Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomised, double-blind, placebo-controlled trial", Lancet, 365, pp.1139~1146 (2005)
38. O'Brien KL, "Efficacy and safety of sevenvalent conjugate pneumococcal vaccine in American Indian children: group randomised trial", Lancet, 362, pp.355~361 (2003)
39. "Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. 22", Wkly Epidemiol Rec, 82, pp.93~104 (2007)
40. Cherian T, "Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies", Bull World Health Organ, 83, pp.353~359 (2005)
41. Madhi SA, "The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIVinfected and -uninfected children", Clin Infect Dis, 40, pp.1511~1518 (2005)
42. Madhi SA, "World Health Organisation definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines", Vaccine, 25, pp.2413~2419 (2007)
43. Grijalva CG, "Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis", Lancet, 369, pp.1179~1186 (2007)
44. Michelow IC, "Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children", Pediatrics, 113, pp.701~707 (2004)
45. Madhi SA, "A role for Streptococcus pneumoniae in virus-associated pneumonia", Nat Med, 10, pp.811~813 (2004)
46. Klugman KP, "Pneumococcal vaccines and flu preparedness", Science, 316, pp.49~50 (2007)
47. Whitney CG, "Decline in invasive pneumococcal disease after the introduction of protein- polysaccharide conjugate vaccine", N Engl J Med, 348, pp.1737~1746 (2003)
48. Centers for Disease Control and Prevention, "Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003", MMWR Morb Mortal Wkly Rep, 54, pp.893~897 (2005)
49. Singleton RJ, "Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage", JAMA, 297, pp.1784~1792 (2007)
50. Smith S, "Vaccines for preventing influenza in healthy children", Cochrane Database Syst Rev, 1, pp.CD004879~ (2006)
51. Allison MA, "Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season", J Pediatr, 149, pp.755~762 (2006)

관련 논문AI추천